Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone [3]

  • Park Y.H.; 
  • Kim S.; 
  • Choi S.-J.; 
  • Ryoo B.-Y.; 
  • Yang S.H.; 
  • 외 5명
Citations

SCOPUS

30

초록

[No abstract available]

키워드

antineoplastic agent; fluorodeoxyglucose; adolescent; adult; aged; autologous hematopoietic stem cell transplantation; bone cancer; cancer adjuvant therapy; cancer recurrence; cancer staging; clinical article; clinical trial; computer assisted tomography; controlled clinical trial; controlled study; drug response; female; follow up; human; intermethod comparison; Korea; letter; male; medical decision making; nonhodgkin lymphoma; nuclear magnetic resonance imaging; positron emission tomography; priority journal; salvage therapy; sensitivity analysis; Adult; Aged; Bone Neoplasms; Decision Making; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Whole-Body Counting
제목
Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone [3]
저자
Park Y.H.; Kim S.; Choi S.-J.; Ryoo B.-Y.; Yang S.H.; Cheon G.J.; Choi C.-W.; Lim S.M.; Yoo J.Y.; Lee S.-S.
DOI
10.1093/annonc/mdi234
발행일
2005
유형
Letter
저널명
Annals of Oncology
권
16
호
8
페이지
1401 ~ 1402